These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39155288)

  • 1. Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software.
    Engesser C; Henkel M; Alargkof V; Fassbind S; Studer J; Engesser J; Walter M; Elyan A; Dugas S; Trotsenko P; Sutter S; Eckert C; Hofmann S; Stalder A; Seifert H; Cornford P; Stieltjes B; Wetterauer C
    Sci Rep; 2024 Aug; 14(1):19113. PubMed ID: 39155288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiple-scenario assessment of the effect of a continuous-care, guideline-based decision support system on clinicians' compliance to clinical guidelines.
    Shalom E; Shahar Y; Parmet Y; Lunenfeld E
    Int J Med Inform; 2015 Apr; 84(4):248-62. PubMed ID: 25649843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with AI Pathway Companion: Evaluation of dashboard-enhanced clinical decision making in prostate cancer screening.
    Henkel M; Horn T; Leboutte F; Trotsenko P; Dugas SG; Sutter SU; Ficht G; Engesser C; Matthias M; Stalder A; Ebbing J; Cornford P; Seifert H; Stieltjes B; Wetterauer C
    PLoS One; 2022; 17(7):e0271183. PubMed ID: 35857753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a software-based decision support tool for guideline-appropriate preoperative evaluation: a prospective agreement study.
    Kagerbauer SM; Wißler J; Andonov DI; Ulm B; Schneider G; Podtschaske AH; Blobner M; Jungwirth B
    Br J Anaesth; 2024 Sep; 133(3):519-529. PubMed ID: 38971713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical practice guidelines in cancerology: comparative study of three decision support-systems for breast and prostate cancer in Lorraine french region].
    Rios M; Desandes E; Bresson B; Klein I; Lesur A; Boisson F; Demange V; Bey P
    Bull Cancer; 2003 Apr; 90(4):363-70. PubMed ID: 12801820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial.
    Arts DL; Abu-Hanna A; Medlock SK; van Weert HC
    PLoS One; 2017; 12(2):e0170974. PubMed ID: 28245247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with biopsy recommendations of a prostate cancer risk calculator.
    van Vugt HA; Roobol MJ; Busstra M; Kil P; Oomens EH; de Jong IJ; Bangma CH; Steyerberg EW; Korfage I
    BJU Int; 2012 May; 109(10):1480-8. PubMed ID: 21933335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
    Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
    J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.
    Wollersheim BM; van Asselt KM; van der Poel HG; van Weert HCPM; Hauptmann M; Retèl VP; Aaronson NK; van de Poll-Franse LV; Boekhout AH
    BMC Cancer; 2020 Jul; 20(1):635. PubMed ID: 32641023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
    Distler FA; Pahernik S; Gakis G; Hutterer G; Lebentrau S; Rink M; Nuhn P; Brookman-May S; Burger M; Gratzke C; Wolff I; May M
    World J Urol; 2020 Oct; 38(10):2523-2530. PubMed ID: 31834472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline of guidelines: prostate cancer screening.
    Loeb S
    BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between use of a clinical decision support tool and adherence to monitoring for medication-laboratory guidelines in the ambulatory setting.
    Lau B; Overby CL; Wirtz HS; Devine EB
    Appl Clin Inform; 2013; 4(4):476-98. PubMed ID: 24454577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of digital clinical decision support tool in improving quality of intrapartum and postpartum care: experiences from two states of India.
    Usmanova G; Lalchandani K; Srivastava A; Joshi CS; Bhatt DC; Bairagi AK; Jain Y; Afzal M; Dhoundiyal R; Benawri J; Chaudhary T; Mishra A; Wadhwa R; Sridhar P; Bahl N; Gaikwad P; Sood B
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):278. PubMed ID: 33827459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience.
    Korman H; Lanni T; Shah C; Parslow J; Tull J; Ghilezan M; Krauss D; Balaraman S; Kernen K; Cotant M; Margolis J; Vicini FA
    Am J Clin Oncol; 2013 Apr; 36(2):121-5. PubMed ID: 22307214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].
    Groeben C; Baunacke M; Borkowetz A; Kliesch S; Wülfing C; Ihrig A; Huber J
    Urologe A; 2016 Jun; 55(6):784-91. PubMed ID: 26969330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling guidelines for integration into clinical workflow.
    Tu SW; Musen MA; Shankar R; Campbell J; Hrabak K; McClay J; Huff SM; McClure R; Parker C; Rocha R; Abarbanel R; Beard N; Glasgow J; Mansfield G; Ram P; Ye Q; Mays E; Weida T; Chute CG; McDonald K; Molu D; Nyman MA; Scheitel S; Solbrig H; Zill DA; Goldstein MK
    Stud Health Technol Inform; 2004; 107(Pt 1):174-8. PubMed ID: 15360798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.
    Shelton JB; Ochotorena L; Bennett C; Shekelle P; Kwan L; Skolarus T; Goldzweig C
    J Gen Intern Med; 2015 Aug; 30(8):1133-9. PubMed ID: 25740462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.